BEVERLY, MA--(Marketwired - September 22, 2016) - BioVie Inc. (OTC PINK: BIVI) (the "Company"), a development-stage company focused on the discovery, development, and commercialization of innovative drug therapies, announced that its scientific team has completed an assessment of the link between n...

BEVERLY, MA--(Marketwired - September 09, 2016) - BioVie Inc. (OTC PINK: BIVI) (the "Company"), a development-stage company focused on the discovery, development, and commercialization of innovative drug therapies, announced today that the Food and Drug Administration's Office of Orphan Products Dev...

BEVERLY, MA--(Marketwired - August 22, 2016) - BioVie Inc. (OTC PINK: BIVI) (the "Company," formerly NanoAntibiotics, Inc.), a development-stage company focused on the discovery, development, and commercialization of innovative drug therapies, announced today that shareholders have approved changin...